3-benzofuranyl-4-indolyl maleimides (University of Illinois)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3-benzofuranyl-4-indolyl maleimides (University of Illinois)
Drug Alias Nameglycogen synthase kinase-3 beta inhibitors (University of Illinois)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsMental DisordersDiabetes Mellitus, Type 2Cardiovascular Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of IllinoisUniversity Of Illinois At Urbana–Champaign
Active IndicationsN/A
Inactive IndicationsMental DisordersDiabetes Mellitus, Type 2Cardiovascular Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A